Wells Fargo’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-1,088
Closed -$6K 6696
2015
Q2
$6K Buy
1,088
+674
+163% +$4.78K ﹤0.01% 5990
2015
Q1
$4K Buy
414
+69
+20% +$711 ﹤0.01% 5890
2014
Q4
$4K Buy
345
+2
+0.6% +$27 ﹤0.01% 5933
2014
Q3
$5K Sell
343
-186
-35% -$2.7K ﹤0.01% 5838
2014
Q2
$8K Buy
+529
New +$8.03K ﹤0.01% 5709

Other funds holding TRIV

Wells Fargo's TRIV Position: Q3 2015 in Review

Wells Fargo sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q3 2015, closing a stake of 1,088 shares — an estimated $6K sold.

Wells Fargo first reported a position in TRIV in Q2 2014 and held it in 5 quarters. The position peaked at $8K in Q2 2014. 26 funds tracked by Wall St. Rank hold TRIV as of Q3 2015.

  • Wells Fargo reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q3 2015 after selling out during the quarter.
  • Wells Fargo sold 1,088 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q3 2015, an estimated $6K.
  • Wells Fargo first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2014 and held it in 5 quarters.
  • Wells Fargo's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $8K in Q2 2014.
  • 26 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q3 2015.

Based on Wells Fargo's 13F filing for Q3 2015, filed 13 Nov 2015.